Mark Lampert is the founder and president of the Biotechnology Value Fund, L.P., a San Francisco-based private investment firm established in 1993. Mark was a Vice President at the investment banking firm Oppenheimer & Co. in New York and founded Biotechnology Royalty Corp., which pooled biotechnology patent royalties owned by universities. He also headed business development for Cambridge NeuroScience and served as Assistant to the President of the NutraSweet Company, a subsidiary of G.D. Searle & Co. Mark started his career at the Boston Consulting Group. He is currently a director of Acumen, Inc., Biotica Technology, Ltd, and Mendel Biotechnology and a trustee of the Lampert Family Foundation. Mark holds an AB Degree in chemistry from Harvard College and an MBA Degree from Harvard Business School.